CSBR Return on Tangible Equity | CHAMPIONS ONCOLOGY, INC.

CHAMPIONS ONCOLOGY, INC. (CSBR) Return on Tangible Equity

2026-04-30: Return Tang Equity -30.91%.
2026-01-31: Return Tang Equity -57.80%.
2025-10-31: Return Tang Equity 64.98%.
2025-07-31: Return Tang Equity 93.03%.

Complete source-backed return tang equity history.

Available history: 2011-04-30 to 2026-04-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-04-30	-30.91%
2026-01-31	-57.80%
2025-10-31	64.98%
2025-07-31	93.03%
2025-04-30	136.78%
2025-01-31	125.19%
2024-10-31	-172.83%
2024-07-31	509.30%
2024-04-30	325.11%
2024-01-31	406.52%
2023-10-31	3982.23%
2023-07-31	-483.55%
2023-04-30	-124.04%
2023-01-31	-46.34%
2022-10-31	1.22%
2022-07-31	4.64%
2022-04-30	6.25%
2022-01-31	2.46%
2021-10-31	5.05%
2021-07-31	1.60%
2021-04-30	5.10%
2021-01-31	-14.58%
2020-10-31	-30.71%
2020-07-31	-32.99%
2020-04-30	-50.88%
2020-01-31	-10.57%
2019-10-31	-66.16%
2019-07-31	-94.05%
2019-04-30	8.72%
2019-01-31	-15.18%
2018-10-31	3.17%
2018-07-31	483.33%
2018-04-30	221.62%
2018-01-31	1659.00%
2017-10-31	1554.44%
2017-07-31	1322.20%
2017-04-30	2558.95%
2017-01-31	-512.97%
2016-10-31	-316.89%
2016-07-31	-402.08%
2016-04-30	2423.88%
2016-01-31	-726.43%
2015-10-31	-348.21%
2015-07-31	-238.52%
2015-04-30	-177.52%
2015-01-31	243.38%
2014-10-31	374.83%
2014-07-31	3787.83%
2014-04-30	-292.56%
2014-01-31	-187.84%
2013-10-31	56.56%
2013-07-31	62.63%
2013-04-30	64.13%
2013-01-31	82.67%
2012-10-31	96.35%
2012-07-31	122.06%
2012-04-30	145.54%
2012-01-31	218.50%
2011-10-31	246.83%
2011-07-31	315.95%
2011-04-30	584.92%

Annual Return Tang Equity

Date	Return Tang Equity
2026-04-30	-32.60%
2025-04-30	136.78%
2024-04-30	325.11%
2023-04-30	-124.04%
2022-04-30	6.25%
2021-04-30	5.10%
2020-04-30	-43.93%
2019-04-30	8.72%
2018-04-30	221.62%
2017-04-30	2559.11%
2016-04-30	2423.56%
2015-04-30	-177.81%
2014-04-30	-292.96%
2013-04-30	64.10%
2012-04-30	145.64%
2011-04-30	584.92%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BioStem Technologies, Inc. (BSEM)	United States	$0.069B
Kalaris Therapeutics, Inc. (KLRS)	United States	$0.073B	-2.19
Eloxx Pharmaceuticals, Inc. (ELOX)	United States	$0.065B
MiNK Therapeutics, Inc. (INKT)	United States	$0.063B	-5.37
Vaxart, Inc. (VXRT)	United States	$0.080B	3.84
EXOZYMES INC. (EXOZ)	United States	$0.058B
BioAtla, Inc. (BCAB)	United States	$0.058B	-0.21
ImageneBio, Inc. (IMA)	United States	$0.056B	-1.31
Inmune Bio, Inc. (INMB)	United States	$0.056B	-2.48
Atara Biotherapeutics, Inc. (ATRA)	United States	$0.086B	-6.48